Your browser is no longer supported. Please, upgrade your browser.
Settings
PBYI Puma Biotechnology, Inc. daily Stock Chart
PBYI [NASD]
Puma Biotechnology, Inc.
Index- P/E- EPS (ttm)-3.90 Insider Own11.30% Shs Outstand37.83M Perf Week0.90%
Market Cap892.03M Forward P/E- EPS next Y-1.54 Insider Trans-0.42% Shs Float33.06M Perf Month-45.88%
Income-147.00M PEG- EPS next Q-0.78 Inst Own93.10% Short Float14.23% Perf Quarter-43.92%
Sales201.50M P/S4.43 EPS this Y5.20% Inst Trans-2.57% Short Ratio3.80 Perf Half Y-54.91%
Book/sh1.21 P/B19.49 EPS next Y56.70% ROA-74.10% Target Price42.78 Perf Year-77.14%
Cash/sh3.38 P/C6.97 EPS next 5Y- ROE-301.50% 52W Range17.60 - 108.50 Perf YTD-76.15%
Dividend- P/FCF- EPS past 5Y-18.10% ROI-287.20% 52W High-78.27% Beta0.07
Dividend %- Quick Ratio3.00 Sales past 5Y- Gross Margin86.00% 52W Low33.98% ATR2.68
Employees318 Current Ratio3.00 Sales Q/Q926.20% Oper. Margin-69.30% RSI (14)29.64 Volatility5.98% 8.71%
OptionableYes Debt/Eq2.64 EPS Q/Q82.00% Profit Margin-72.90% Rel Volume0.89 Prev Close22.61
ShortableYes LT Debt/Eq2.64 EarningsNov 01 AMC Payout- Avg Volume1.24M Price23.58
Recom2.90 SMA20-23.98% SMA50-40.65% SMA200-55.83% Volume1,101,902 Change4.29%
Nov-02-18Downgrade JP Morgan Neutral → Underweight
Nov-02-18Downgrade BofA/Merrill Buy → Underperform
Oct-01-18Initiated Cantor Fitzgerald Overweight $75
Sep-17-18Initiated Goldman Sell $42
May-11-18Reiterated Stifel Buy $95 → $87
Nov-10-17Reiterated RBC Capital Mkts Sector Perform $92 → $108
Nov-10-17Reiterated Citigroup Buy $156 → $164
Oct-02-17Reiterated Stifel Buy $110 → $130
Sep-11-17Reiterated Credit Suisse Outperform $118 → $136
Jul-10-17Resumed Leerink Partners Outperform $115
Jun-06-17Reiterated RBC Capital Mkts Sector Perform $60 → $88
May-25-17Reiterated RBC Capital Mkts Sector Perform $40 → $60
Mar-02-17Reiterated RBC Capital Mkts Sector Perform $48 → $17
Sep-22-16Reiterated Credit Suisse Outperform $54 → $111
Sep-21-16Upgrade Stifel Hold → Buy $61 → $88
Mar-29-16Downgrade RBC Capital Mkts Outperform → Sector Perform $103 → $36
Jan-21-16Initiated Credit Suisse Outperform
Dec-14-15Upgrade Citigroup Neutral → Buy
Sep-03-15Initiated Citigroup Neutral
Aug-27-15Initiated JP Morgan Overweight $122
Nov-16-18 07:47AM  Edited Transcript of PBYI earnings conference call or presentation 1-Nov-18 8:30pm GMT Thomson Reuters StreetEvents
Nov-09-18 08:20AM  Investor Expectations to Drive Momentum within Matson, Craft Brew Alliance, Easterly Government Properties, Novanta, Ascena Retail Group, and Puma Biotechnology Discovering Underlying Factors of Influence GlobeNewswire
Nov-07-18 04:15PM  Puma Biotechnology to Present at Credit Suisse Healthcare Conference Business Wire
09:30AM  Biotech Stocks and the Midterm Elections ACCESSWIRE
Nov-05-18 10:25AM  Puma Biotech (PBYI) Q3 Loss Narrows, Nerlynx Pulls Stock Down Zacks +13.90%
Nov-02-18 01:47PM  Here's Why Puma Biotechnology Inc. Is Getting Hammered Today Motley Fool -48.01%
08:52AM  Puma Biotechnology's stock plunges to pace premarket losers after key drug Nerlynx disappoints MarketWatch
Nov-01-18 08:45PM  Puma Biotech (PBYI) Reports Q3 Loss, Tops Revenue Estimates Zacks
07:42PM  Puma Biotech: 3Q Earnings Snapshot Associated Press
05:56PM  Why Puma Biotechnology, Inc. Stock Is Getting Crushed Today Motley Fool
04:10PM  Puma Biotechnology Reports Third Quarter 2018 Financial Results Business Wire
Oct-25-18 10:34AM  Puma Biotech (PBYI) Q3 Earnings Preview: What to Look Out For Zacks
Oct-18-18 04:15PM  Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results Business Wire
11:37AM  Puma Biotech (PBYI) Rides High on Robust Nerlynx Performance Zacks
Oct-17-18 07:20AM  Investor Expectations to Drive Momentum within Arsanis, Dynavax Technologies, Puma Biotechnology, Opko Health, Adaptimmune Therapeutics, and Codexis Discovering Underlying Factors of Influence GlobeNewswire
Oct-16-18 05:51PM  Celcuity Announces Clinical Trial Collaboration with Puma Biotechnology and West Cancer Center Business Wire
Oct-10-18 05:00PM  Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Oct-03-18 08:21AM  3 Top Mid-Cap Stocks to Buy in October Motley Fool
Oct-02-18 08:30AM  Puma Biotechnologys Licensing Partner CANbridge Pharmaceutical Submits New Drug Application for NERLYNX® (neratinib) in China Business Wire
Sep-20-18 04:15PM  Puma Biotechnology to Present at Cantor Global Healthcare Conference Business Wire
Sep-06-18 04:20PM  Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Business Wire
11:09AM  Puma Biotech Gets EU Nod for Breast Cancer Drug Nerlynx Zacks
08:52AM  The Zacks Analyst Blog Highlights: Amgen, Puma Biotechnology, MannKind, United Therapeutics and Vertex Pharmaceuticals Zacks
Sep-05-18 04:17PM  Edited Transcript of PBYI earnings conference call or presentation 9-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
09:39AM  Biotech Stock Roundup: AMGN, PBYI Get EC Nod for Their Drugs, MNKD Soars Zacks
Aug-23-18 10:03AM  Factors of Influence in 2018, Key Indicators and Opportunity within Patterson-UTI Energy, Puma Biotechnology, Echelon, McEwen Mining, New Gold, and Qudian Inc. Sponsored ADR New Research Emphasizes Economic Growth GlobeNewswire
Aug-10-18 10:45AM  Puma Biotech (PBYI) Q2 Loss Narrows, Nerlynx Drives Sales Zacks -8.12%
08:00AM  Today's Research Reports on Trending Tickers: Puma Biotechnology and Corcept Therapeutics ACCESSWIRE
Aug-09-18 06:00PM  Puma Biotech (PBYI) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:57PM  Puma Biotech: 2Q Earnings Snapshot Associated Press
04:47PM  Puma Bio shares jump 19% on narrower quarterly loss, bigger sales MarketWatch
04:05PM  Puma Biotechnology Reports Second Quarter 2018 Financial Results Business Wire
Aug-07-18 11:13AM  What's in the Cards for Puma Biotech (PBYI) in Q2 Earnings? Zacks
Jul-31-18 08:30AM  Puma Biotechnology Files New Drug Submission for NERLYNX® in Canada Business Wire
Jul-30-18 07:00AM  Stock Performance Review on Amicus Therapeutics and Three Other Biotech Stocks ACCESSWIRE
Jul-26-18 04:15PM  Puma Biotechnology to Host Conference Call to Discuss Second Quarter Financial Results Business Wire
Jul-17-18 04:15PM  Puma Biotechnology and Strata Oncology Announce Collaboration to Accelerate Enrollment in Neratinib HER2 Mutation Basket Study (SUMMIT Trial) Business Wire
Jul-13-18 01:30PM  Here's Why Puma Biotechnology Rose 11.7% in June Motley Fool
Jun-29-18 07:30AM  Puma Biotechnology Receives Positive CHMP Opinion Recommending Approval of NERLYNX® for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer Business Wire
Jun-28-18 07:35AM  Complimentary Technical Snapshots on Puma Biotech and Three More Biotech Stocks ACCESSWIRE
Jun-27-18 10:32AM  Puma Biotechnology's Shares Rise on Positive CHMP Trend Vote Zacks -10.62%
08:12AM  Biotech Stock Roundup: PBYI Soars, MACK Crashes, GILD's Biktarvy Gets EC Nod Zacks
08:00AM  Todays Research Reports on Stocks to Watch: Puma Biotechnology and Achieve Life Sciences ACCESSWIRE
Jun-26-18 04:31PM  Why Puma Biotechnology Stock Soared Today Motley Fool +24.36%
04:29PM  Why General Electric, Puma Biotechnology, and Lennar Jumped Today Motley Fool
09:28AM  Puma Biotech says Europe likely to approve breast cancer drug Reuters
08:51AM  Puma Biotechnology Announces Results of CHMP Reexamination of MAA for Neratinib for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer Business Wire
Jun-20-18 04:28PM  Former Puma Biotech executive gets U.S. prison term for insider trading Reuters
Jun-18-18 08:30AM  Champions Oncology Partners with Puma Biotechnology and NSABP Foundation on Metastatic Breast and Colon Cancer Co-clinical PDX Studies PR Newswire
Jun-15-18 08:20AM  Today's Research Reports on Trending Tickers: Puma Biotechnology and bluebird bio ACCESSWIRE
Jun-12-18 07:50AM  Detailed Research: Economic Perspectives on Amphenol, Hologic, Newell Brands, Ciena, SAExploration, and Puma Biotechnology What Drives Growth in Today's Competitive Landscape GlobeNewswire
Jun-02-18 09:00AM  Puma Biotechnology Presents Interim Results of Phase Ib/II FB-10 Trial of PB272 in Combination with Trastuzumab Emtansine (T-DM1) in HER2-Positive Metastatic Breast Cancer at the 2018 ASCO Annual Meeting Business Wire
May-30-18 04:05PM  Puma Biotechnology to Present at Jefferies Global Healthcare Conference Business Wire
May-17-18 10:02PM  Edited Transcript of PBYI earnings conference call or presentation 9-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-16-18 08:20AM  Today's Research Reports on Trending Tickers: Puma Biotechnology and Amicus Therapeutics ACCESSWIRE
May-11-18 08:10AM  Todays Research Reports on Stocks to Watch: Puma Biotechnology and Neovasc ACCESSWIRE
May-10-18 01:06PM  Here's Why Puma Biotechnology Inc. Is Sinking Today Motley Fool -20.67%
May-09-18 05:49PM  Puma Biotech: 1Q Earnings Snapshot Associated Press
04:05PM  Puma Biotechnology Reports First Quarter 2018 Financial Results Business Wire
May-08-18 04:15PM  Puma Biotechnology to Present at Bank of America Merrill Lynch Health Care Conference 2018 Business Wire
May-07-18 08:42AM  Puma Biotech (PBYI) to Report Q1 Earnings: What to Expect? Zacks
Apr-30-18 08:20AM  Today's Research Reports on Trending Tickers: Neovasc and Puma Biotechnology ACCESSWIRE -6.59%
Apr-25-18 04:15PM  Puma Biotechnology to Host Conference Call to Discuss First Quarter Financial Results Business Wire
Apr-03-18 08:45AM  Puma Biotechnology and Pint Pharma Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in Latin America Business Wire
Apr-02-18 11:19AM  Puma's Shares Fall This Year Post a Solid 2017: Here's Why Zacks -5.36%
08:45AM  NCCN Guidelines for Central Nervous System Cancers Include NERLYNX® (neratinib) in Combination With Capecitabine or Paclitaxel as Treatment Options for Patients With Breast Cancer Brain Metastases Business Wire
04:38AM  Puma Biotechnology (PBYI) Up 10.2% Since Earnings Report: Can It Continue? Zacks
Mar-29-18 11:51AM  Puma Biotechnology Inc (NASDAQ:PBYI) Is Trading At A 47% Discount Simply Wall St.
Mar-28-18 11:00AM  Robbins Geller Rudman & Dowd LLP Announces Pending Class Action in the Puma Biotechnology, Inc. Litigation Business Wire
Mar-09-18 08:42AM  Does Puma Biotechnology Incs (NASDAQ:PBYI) -5.79% Earnings Drop Reflect A Longer Term Trend? Simply Wall St.
Mar-06-18 04:15PM  Puma Biotechnology to Present at Cowens Annual Healthcare Conference Business Wire
Mar-02-18 05:51PM  Why Puma Biotechnology Shares Jumped 15% Today Motley Fool +15.06%
02:21PM  Edited Transcript of PBYI earnings conference call or presentation 1-Mar-18 9:30pm GMT Thomson Reuters StreetEvents
11:37AM  Puma (PBYI) Q4 Loss Narrower Than Expected, Shares Down Zacks
Mar-01-18 05:02PM  Puma Biotech reports 4Q loss Associated Press -5.51%
04:05PM  Puma Biotechnology Reports Fourth Quarter and Full Year 2017 Financial Results Business Wire
12:00PM  Puma Biotechnology, Inc. to Host Earnings Call ACCESSWIRE
Feb-27-18 07:20AM  Blog Exposure - CHMP Recommended Against Approval of Puma Biotech's Neratinib for Extended Adjuvant Treatment of HER2-Positive Breast Cancer ACCESSWIRE
Feb-26-18 10:06AM  Heres Whats Moving KemPharm And Puma Biotechnology Market Exclusive
Feb-23-18 07:30AM  Puma Biotechnology Receives Results of CHMP Formal Decision for Neratinib for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer Business Wire
Feb-20-18 08:30AM  New Research Coverage Highlights SunCoke Energy Partners, Carrols Restaurant Group, First Financial, Emerson Electric, Puma Biotechnology, and Amgen Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Feb-15-18 04:15PM  Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results Business Wire
08:10AM  Todays Research Reports on Trending Tickers: Nektar Therapeutics and Puma Biotechnology ACCESSWIRE
Feb-07-18 04:15PM  Puma Biotechnology to Present at LEERINK Partners Global Healthcare Conference Business Wire
Feb-02-18 10:00AM  Puma, CANbridge Team Up to Commercialize Nerlynx in China Zacks
Feb-01-18 04:15PM  Puma Biotechnology and CANbridge Life Sciences Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in Greater China Business Wire
Jan-31-18 01:16PM  Puma Biotechnology Announces Publication of Results from Phase II SUMMIT Basket Trial Evaluating Neratinib in HER2 and HER3 Mutant Cancers Business Wire
09:17AM  Puma & Medison Team Up to Commercialize Nerlynx in Israel Zacks
Jan-30-18 04:15PM  A Licensing Agreement Won't Protect This Biotech From A Takeover Investor's Business Daily
08:39AM  Do Options Traders Know Something About Puma Biotechnology (PBYI) Stock We Don't? Zacks
08:15AM  Puma Biotechnology and Medison Pharma Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in Israel Business Wire
Jan-29-18 04:20PM  Puma Biotechnology Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Jan-25-18 08:00AM  Todays Research Reports on Stocks to Watch: Valeant Pharmaceuticals and Puma Biotechnology ACCESSWIRE +5.26%
Jan-24-18 05:20PM  ICYMI: MicroCap Trading Ideas, Puma Biotech, A Valeant Bear Call Benzinga -28.82%
04:44PM  Why Texas Instruments, Puma Biotechnology, and Delta Air Lines Slumped Today Motley Fool
03:22PM  EU Unlikely to Approve Puma's Nerlynx in 2018, Stock Down Zacks
02:11PM  What Happened To Puma Biotechnology? Forbes
11:04AM  Here's Why Puma Biotechnology Inc. Is Getting Beaten Down Today Motley Fool
10:34AM  Puma Biotechnology Inc: A European Approval for Neratinib Seems Unlikely SmarterAnalyst
10:13AM  With EU Approval For Puma Biotech's Breast Cancer Drug Unlikely, Cowen Downgrades Benzinga
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States. Its drug candidates include PB272 neratinib (oral) for the treatment of early stage breast cancer, metastatic breast cancer, non-small cell lung cancer, HER2 mutation-positive solid tumors, and HER2-mutated non-amplified breast cancer; and PB272 neratinib (intravenous)). The company also develops PB357, an orally administered agent that is an irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2, and HER4. It has a license agreement with Pfizer, Inc. for the development, manufacture, and commercialization of PB272 neratinib (oral), PB272 neratinib (intravenous), PB357, and certain related compounds. Puma Biotechnology, Inc. was founded in 2010 and is headquartered in Los Angeles, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lo StevenChief Commercial OfficerJul 20Sale51.851,83995,36023,523Jul 24 05:10 PM
EYLER CHARLES RSEE REMARKSJul 20Sale51.9561031,69035,206Jul 24 05:07 PM
BRYCE RICHARD PAULSEE REMARKSJul 20Sale51.951,83695,38132,543Jul 24 05:03 PM
AUERBACH ALAN HPRESIDENT AND CEOJul 20Sale52.0012,520651,0204,179,061Jul 24 05:00 PM
EYLER CHARLES RSEE REMARKSJun 01Sale53.001,21164,18335,816Jun 04 05:08 PM
Lo StevenChief Commercial OfficerJan 22Sale92.851,858172,51525,362Jan 24 04:38 PM
BRYCE RICHARD PAULSR VP, CLINICAL RESEARCH & DEVJan 22Sale92.751,860172,51525,379Jan 24 04:33 PM
AUERBACH ALAN HPRESIDENT AND CEOJan 22Sale92.7510,692991,6834,155,931Jan 24 04:30 PM
EYLER CHARLES RSEE REMARKSDec 01Sale105.461,322139,42428,696Dec 05 04:06 PM